Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Peter Glazer"'
Autor:
Ahmed Taher, Peter Glazer, Chris Culligan, Stephanie Crump, Steven Guirguis, Jennifer Jones, Alia Dharamsi, Lucas B. Chartier
Publikováno v:
International Journal of Emergency Medicine, Vol 15, Iss 1, Pp 1-8 (2022)
Abstract Background Decreasing healthcare provider (HCP) exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus in emergency departments (EDs) is crucial. Approaches include limiting the HCP presence and ensuring sealed is
Externí odkaz:
https://doaj.org/article/e92f222e2ee940b59893e75355806694
Autor:
Wu Liu, John Deacon, Huagang Yan, Bo Sun, Yanfeng Liu, Denise Hegan, Qin Li, Daniel Coman, Maxime Parent, Fahmeed Hyder, Kenneth Roberts, Ravinder Nath, Olivier Tillement, Donald Engelman, Peter Glazer
Publikováno v:
Translational Oncology, Vol 13, Iss 11, Pp 100839- (2020)
Tumor targeting studies using metallic nanoparticles (NPs) have shown that the enhanced permeability and retention effect may not be sufficient to deliver the amount of intratumoral and intracellular NPs needed for effective in vivo radiosensitizatio
Externí odkaz:
https://doaj.org/article/30d1b594389c4eb5b8a44207655a2729
Autor:
Elena Favaro, Anassuya Ramachandran, Robert McCormick, Harriet Gee, Christine Blancher, Meredith Crosby, Cecilia Devlin, Christopher Blick, Francesca Buffa, Ji-Liang Li, Borivoj Vojnovic, Ricardo Pires das Neves, Peter Glazer, Francisco Iborra, Mircea Ivan, Jiannis Ragoussis, Adrian L Harris
Publikováno v:
PLoS ONE, Vol 5, Iss 4, p e10345 (2010)
Hypoxia in cancers results in the upregulation of hypoxia inducible factor 1 (HIF-1) and a microRNA, hsa-miR-210 (miR-210) which is associated with a poor prognosis.In human cancer cell lines and tumours, we found that miR-210 targets the mitochondri
Externí odkaz:
https://doaj.org/article/4b262f404a274363b024a45e2a841996
Autor:
Joseph P, Eder, Deborah B, Doroshow, Khanh T, Do, Vicki L, Keedy, Jeffrey S, Sklar, Peter, Glazer, Ranjit, Bindra, Geoffrey I, Shapiro
Publikováno v:
JCO precision oncology. 5
Tumors with neomorphic mutations in IDH1/2 have defective homologous recombination repair, resulting in sensitivity to poly (ADP-ribose) polymerase (PARP) inhibition. The Olaparib Combination trial is a phase II, open-label study in which patients wi
Autor:
Ahmed Taher, Peter Glazer, Chris Culligan, Stephanie Crump, Steven Guirguis, Jennifer Jones, Alia Dharamsi, Lucas B. Chartier
Publikováno v:
International journal of emergency medicine. 15(1)
Background Decreasing healthcare provider (HCP) exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) virus in emergency departments (EDs) is crucial. Approaches include limiting the HCP presence and ensuring sealed isolation r
Autor:
Elias Quijano, Minsoo Khang, Bruce C. Turner, Stephen Squinto, Ranjit Bindra, W. Mark Saltzman, Peter Glazer
Publikováno v:
Molecular Cancer Therapeutics. 20:P135-P135
Targeting tumors of the central nervous system remains challenging given the physiological barriers preventing the delivery of therapeutics across the blood brain barrier (BBB). This is particularly true for nucleic acids, which degrade rapidly in se
Autor:
Elena Quaglino, Staffan Eksborg, Sai Yendamuri, Joost J.C. Verhoeff, Olaf Wolkenhauer, Peter Glazer, Ian Hickson, Nasr Y. A. Hemdan, Maria Paola Paronetto, Andrea Sottoriva, Paulo Rodriguez
Publikováno v:
Cancer Research. 70:1746-1748
Autor:
Peter Glazer
Publikováno v:
Modern Drama. 50:640-642
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:E597
Autor:
Malcolm A. Binns, Gordon Winocur, Rayonne Chavannes, Donald T. Stuss, Melissa Edwards, Fergus I. M. Craik, Kristen Bridges, Heather Palmer, Peter Glazer
Publikováno v:
Journal of the International Neuropsychological Society. 13
This study reports the effects of a 12-week multimodular cognitive rehabilitation training program on memory performance in two groups of older adults. In the Memory Training module, participants were instructed on the nature of memory and how to imp